[Hub]/) : Traits : Systolic Blood Pressure :

chr19:48,464,978-50,108,983

Best TWAS P=3.32e-15 · Best GWAS P=2.07e-15 conditioned to 0.0787

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 CommonMind Brain Pre-frontal Cortex SPHK2 0.08 0.02 blup 467 0.03 3.6e-04 0.77 -5.3 1.3e-07 -0.54 0.23 0.36 FALSE
2 GTEx Adrenal Gland RASIP1 0.20 0.11 lasso 4 0.10 2.4e-04 -5.76 6.2 7.2e-10 0.84 0.03 0.93 FALSE
3 GTEx Cells Transformed fibroblasts RASIP1 0.19 0.14 lasso 6 0.20 6.1e-15 7.13 7.9 3.3e-15 0.92 0.04 0.96 TRUE
4 GTEx Esophagus Mucosa RASIP1 0.13 0.13 lasso 4 0.13 9.0e-09 -6.74 7.3 3.0e-13 0.92 0.03 0.97 FALSE
5 GTEx Esophagus Muscularis NTN5 0.14 0.00 enet 12 0.01 6.5e-02 -6.00 5.5 5.0e-08 0.57 0.02 0.77 FALSE
6 GTEx Heart Atrial Appendage MAMSTR 0.24 0.13 lasso 2 0.13 1.3e-06 -5.34 6.3 3.0e-10 0.82 0.02 0.97 FALSE
7 GTEx Heart Atrial Appendage NUCB1-AS1 0.16 0.04 lasso 3 0.07 5.3e-04 -6.00 -5.2 1.7e-07 -0.49 0.07 0.21 FALSE
8 GTEx Heart Left Ventricle MAMSTR 0.26 0.18 lasso 6 0.21 3.4e-11 -6.02 7.3 2.9e-13 0.92 0.01 0.99 FALSE
9 GTEx Skin Not Sun Exposed Suprapubic RASIP1 0.15 0.04 lasso 6 0.08 2.9e-05 7.94 5.6 2.8e-08 0.87 0.01 0.99 FALSE
10 GTEx Skin Not Sun Exposed Suprapubic NTN5 0.19 0.07 lasso 5 0.08 2.5e-05 6.71 7.4 1.2e-13 0.89 0.06 0.94 FALSE
11 GTEx Skin Sun Exposed Lower leg RASIP1 0.21 0.13 enet 19 0.17 1.1e-13 -6.78 6.9 3.9e-12 0.92 0.01 0.99 FALSE
12 GTEx Skin Sun Exposed Lower leg NTN5 0.11 0.09 enet 18 0.05 6.2e-05 7.13 7.5 7.9e-14 0.82 0.04 0.96 FALSE
13 GTEx Testis RASIP1 0.29 0.20 lasso 8 0.30 7.5e-14 -6.38 7.6 3.9e-14 0.96 0.02 0.98 FALSE
14 GTEx Testis NTN5 0.16 0.02 enet 23 0.06 9.6e-04 6.62 5.2 1.5e-07 0.56 0.04 0.63 FALSE
15 METSIM Adipose FUT1 0.04 0.01 lasso 6 0.02 6.9e-04 -4.72 -5.5 4.8e-08 -0.69 0.11 0.73 FALSE
16 The Cancer Genome Atlas Bladder Urothelial Carcinoma FUT2 0.05 0.01 blup 52 0.01 6.1e-02 7.89 -7.5 6.7e-14 -0.94 0.00 0.86 FALSE
17 The Cancer Genome Atlas Breast Invasive Carcinoma FUT2 0.03 0.05 blup 54 0.05 1.9e-10 7.13 -6.9 4.9e-12 -0.84 0.35 0.65 FALSE
18 The Cancer Genome Atlas Breast Invasive Carcinoma NTN5 0.02 0.01 enet 11 0.01 7.6e-04 6.64 6.8 7.6e-12 0.68 0.01 0.91 FALSE
19 The Cancer Genome Atlas Breast Invasive Carcinoma RASIP1 0.02 0.02 blup 56 0.03 3.8e-07 6.33 7.4 1.3e-13 0.92 0.01 0.99 FALSE
20 The Cancer Genome Atlas Cervical Squamous Cell Carcinoma FUT2 0.10 0.02 blup 55 0.06 6.8e-04 6.64 -7.0 1.9e-12 -0.83 0.18 0.72 FALSE
21 The Cancer Genome Atlas Colon Adenocarcinoma FUT2 0.18 0.22 enet 12 0.18 6.8e-11 6.71 -6.8 8.3e-12 -0.81 0.87 0.13 FALSE
22 The Cancer Genome Atlas Colon Adenocarcinoma SEC1 0.05 0.04 enet 11 0.01 8.5e-02 6.67 -6.8 8.2e-12 -0.73 0.02 0.82 FALSE
23 The Cancer Genome Atlas Esophageal Carcinoma FUT2 0.33 0.27 lasso 3 0.24 3.9e-08 -6.00 -6.2 6.4e-10 -0.67 0.63 0.34 FALSE
24 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma FUT2 0.11 0.22 blup 52 0.22 6.3e-24 7.11 -7.1 1.4e-12 -0.86 0.58 0.42 FALSE
25 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma RASIP1 0.04 0.01 enet 10 0.02 2.3e-03 -5.34 6.2 7.8e-10 0.64 0.11 0.70 FALSE
26 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma FUT2 0.10 0.01 blup 51 0.05 9.8e-04 6.68 -7.2 4.3e-13 -0.82 0.03 0.82 FALSE
27 The Cancer Genome Atlas Brain Lower Grade Glioma FUT2 0.02 0.04 lasso 1 0.03 1.8e-04 -5.34 -5.3 9.2e-08 -0.70 0.07 0.60 FALSE
28 The Cancer Genome Atlas Brain Lower Grade Glioma MAMSTR 0.04 0.04 blup 47 0.06 3.9e-07 -5.76 6.7 2.5e-11 0.83 0.23 0.77 FALSE
29 The Cancer Genome Atlas Brain Lower Grade Glioma NTN5 0.05 0.04 lasso 2 0.02 6.7e-04 6.33 6.3 2.4e-10 0.82 0.01 0.98 FALSE
30 The Cancer Genome Atlas Lung Adenocarcinoma FUT2 0.09 0.12 blup 52 0.12 4.2e-14 6.64 -7.2 5.7e-13 -0.85 0.63 0.37 FALSE
31 The Cancer Genome Atlas Lung Squamous Cell Carcinoma FUT2 0.05 0.08 lasso 2 0.08 6.7e-09 6.68 -6.7 1.6e-11 -0.79 0.80 0.20 FALSE
32 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma FUT2 0.06 0.00 blup 53 0.05 3.5e-04 7.89 -7.2 6.3e-13 -0.86 0.01 0.92 FALSE
33 The Cancer Genome Atlas Pancreatic Adenocarcinoma FUT2 0.08 0.12 lasso 4 0.11 2.5e-05 7.13 -7.1 9.7e-13 -0.78 0.07 0.83 FALSE
34 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma IZUMO1 0.16 0.17 lasso 7 0.15 1.4e-06 -6.74 6.9 5.1e-12 0.86 0.30 0.67 FALSE
35 The Cancer Genome Atlas Prostate Adenocarcinoma FUT2 0.05 0.06 blup 52 0.06 8.6e-07 7.11 -7.7 1.9e-14 -0.91 0.04 0.96 FALSE
36 The Cancer Genome Atlas Rectum Adenocarcinoma FUT2 0.26 0.28 lasso 10 0.22 5.2e-06 6.33 -6.8 1.3e-11 -0.86 0.09 0.85 FALSE
37 The Cancer Genome Atlas Soft Tissue Sarcoma RASIP1 0.05 0.06 blup 54 0.04 1.4e-03 -6.00 6.5 1.2e-10 0.77 0.05 0.41 FALSE
38 The Cancer Genome Atlas Stomach Adenocarcinoma FUT2 0.14 0.16 lasso 8 0.14 4.9e-10 7.13 -7.0 1.9e-12 -0.80 0.63 0.37 FALSE
39 The Cancer Genome Atlas Testicular Germ Cell Tumors FUT2 0.22 0.09 lasso 8 0.13 3.0e-05 -3.63 -6.3 2.1e-10 -0.71 0.10 0.86 FALSE
40 The Cancer Genome Atlas Thyroid Carcinoma FUT2 0.06 0.04 blup 54 0.06 1.1e-06 -6.00 -7.2 6.5e-13 -0.88 0.03 0.96 FALSE
41 The Cancer Genome Atlas Thyroid Carcinoma NTN5 0.11 0.07 blup 43 0.09 2.6e-09 6.64 6.5 6.8e-11 0.75 0.05 0.95 FALSE